Roche Enjoined In Patent Battle With Amgen
Roche Holdings AG has been preliminarily barred from selling the anemia drug Mircera in the U.S. while the court considers granting Amgen Inc.'s bid for a permanent injunction....To view the full article, register now.
Already a subscriber? Click here to view full article